EUVIMEDOpdag EUVIMED
MetaanalyseÜbersichtsarbeitOpen access

Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis

Wen Hui Lim, Phoebe Tay, Cheng Han Ng iD, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Muthiah iD and 8 more

Alimentary Pharmacology & Therapeutics · 2024-03 · 59 (6) · 730-741

DOI: 10.1111/apt.17888 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, 2024-02. Written by Wen Hui Lim and 19 co-authors. Institution: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Major MEDLINE topics: Alcohol Abstinence, Liver Cirrhosis, Alcoholic. Cited 31 times so far (Crossref); 66 references. The full text is freely available in PubMed Central. Funded by: NCATS NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Although alcohol abstinence may be an effective intervention for alcohol‐associated cirrhosis, its association with prognosis has not been systematically assessed or quantified.

Aims

To determine the prevalence of alcohol abstinence, factors associated with alcohol abstinence and the impact of abstinence on morbidity and overall survival in people with alcohol‐associated cirrhosis.

Methods

We searched Medline and Embase from inception to 15 April 2023 for prospective and retrospective cohort studies describing alcohol abstinence in people with known alcohol‐associated cirrhosis. Meta‐analysis of proportions for pooled estimates was performed. The method of inverse variance, employing a random‐effects model, was used to pool the hazard ratio (HR) comparing outcomes of abstinent against non‐abstinent individuals with alcohol‐associated cirrhosis.

Results

We included 19 studies involving 18,833 people with alcohol‐associated cirrhosis. The prevalence of alcohol abstinence was 53.8% (CI: 44.6%–62.7%). Over a mean follow‐up duration of 48.6 months, individuals who continued to consume alcohol had significantly lower overall survival compared to those who were abstinent (HR: 0.611, 95% CI: 0.506–0.738). These findings remained consistent in sensitivity/subgroup analysis for the presence of decompensation, study design and studies that assessed abstinence throughout follow‐up. Alcohol abstinence was associated with a significantly lower risk of hepatic decompensation (HR: 0.612, 95% CI: 0.473–0.792).

Conclusions

Alcohol abstinence is associated with substantial improvement in overall survival in alcohol‐associated cirrhosis. However, only half of the individuals with known alcohol‐associated cirrhosis are abstinent.

Subjects

MeSH terms (MEDLINE)

Alcohol AbstinenceLiver Cirrhosis, AlcoholicHumansProspective StudiesRetrospective StudiesPrevalence

Author keywords

abstinencecirrhosishepatocellular carcinomaprevalencesurvival

Authors and institutions

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.
  • National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.
  • School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
  • Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Liver Center, Saga Medical School, Saga University, Saga, Japan.

ORCID profiles: Cheng Han Ng, Mark Muthiah, Karn Wijarnpreecha, Mazen Noureddin, Rohit Loomba, Daniel Q Huang

Funding

  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NIAAA NIH HHS
  • NHLBI NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • National Institute on Alcohol Abuse and Alcoholism

Cite

APA

Lim, W. H., Tay, P., Ng, C. H., Tan, D. J. H., Ong, C., Koh, J. H., Teng, M., Chee, D., Wong, Z. Y., Kawaguchi, T., Takahashi, H., Muthiah, M., Tan, E. X. X., Wijarnpreecha, K., Lee, G. H., Noureddin, M., Lee, B. P., Mathurin, P., Loomba, R., & Huang, D. Q. (2024). Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics, 59(6), 730-741. https://doi.org/10.1111/apt.17888

Vancouver

Lim WH, Tay P, Ng CH, Tan DJH, Ong C, Koh JH, et al. Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics. 2024;59(6):730-741. doi:10.1111/apt.17888

BibTeX
@article{Lim2024,
  author = {Lim, Wen Hui and Tay, Phoebe and Ng, Cheng Han and Tan, Darren Jun Hao and Ong, Christen and Koh, Jia Hong and Teng, Margaret and Chee, Douglas and Wong, Zhen Yu and Kawaguchi, Takumi and Takahashi, Hirokazu and Muthiah, Mark and Tan, Eunice X X and Wijarnpreecha, Karn and Lee, Guan Huei and Noureddin, Mazen and Lee, Brian P and Mathurin, Philippe and Loomba, Rohit and Huang, Daniel Q},
  title = {Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {59},
  number = {6},
  pages = {730--741},
  doi = {10.1111/apt.17888}
}
Start for free →